newsfilter
← Latest News
GlobeNewswire·

Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical

SAN DIEGO and TORONTO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO, TSX:APS), a clinical-stage precision oncology company developing highly differentiated oral